Clin Exp Vaccine Res.  2015 Jul;4(2):137-144. 10.7774/cevr.2015.4.2.137.

Safety of influenza vaccination in children with allergic diseases

• Yang HJ

• KMID: 1965398
• DOI: http://doi.org/10.7774/cevr.2015.4.2.137

Abstract

Global guidelines strongly recommend annual influenza vaccination in people age 6 months and older, particularly in asthmatic children. There is no doubt about the benefit of influenza vaccination in asthmatic children. However, some of the vaccine's components may elicit an IgE mediated hypersensitivity or disease exacerbation, including life-threatening events, in children with allergic diseases. As a result, concerns regarding the safety of the vaccine still continue today. The influenza vaccine is grown on hens' eggs and contains a trace of egg protein. Consequently, it can provoke an allergic reaction or anaphylaxis in children with an egg allergy or exacerbation in those with asthma. Therefore, we need to know the risks and benefits of the influenza vaccine and the best strategy for safe vaccination. Although most guidelines have consistently reported the safety of influenza vaccination in children with allergic disease, and have recommended annual administration, safety concerns impede guideline-based performance in practice. The safety and efficacy of influenza vaccination for allergic children are summarized in the present review.

Keyword

Asthma; Egg hypersensitivity; Child; Influenza; Vaccines

MeSH Terms

Anaphylaxis
Asthma
Child*
Disease Progression
Egg Hypersensitivity
Eggs
Humans
Hypersensitivity
Hypersensitivity, Immediate
Influenza Vaccines
Influenza, Human*
Ovum
Risk Assessment
Vaccination*
Vaccines
Influenza Vaccines
Vaccines

Reference

1. Lee SI. Prevalence of childhood asthma in Korea: international study of asthma and allergies in childhood. Allergy Asthma Immunol Res. 2010; 2:61–64.

2. Huang C, Liu W, Hu Y, et al. Updated prevalences of asthma, allergy, and airway symptoms, and a systematic review of trends over time for childhood asthma in Shanghai, China. PLoS One. 2015; 10:e0121577.

3. Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010; 65:152–167.

4. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol. 2011; 127:594–602.

5. Park M, Kim D, Ahn K, Kim J, Han Y. Prevalence of immediate-type food allergy in early childhood in seoul. Allergy Asthma Immunol Res. 2014; 6:131–136.

6. Ahn K, Kim J, Hahm MI, et al. Prevalence of immediate-type food allergy in Korean schoolchildren: a population-based study. Allergy Asthma Proc. 2012; 33:481–487.

7. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012; 87:461–476.

8. Kelso JM. Administering influenza vaccine to egg-allergic persons. Expert Rev Vaccines. 2014; 13:1049–1057.

9. Nah SY, Hong JT, Im JH, et al. Variations in number of hospitalized patients with cardiopulmonary diseases associated with 2009 H1N1 pandemic influenza in a tertiary teaching hospital: comparison with seasonal influenza. Infect Chemother. 2011; 43:390–395.

10. Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine. 2000; 18:2288–2294.

11. Kang JH. Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy. Korean J Pediatr. 2014; 57:164–170.

12. Liu J, Ai H, Xiong Y, et al. Prevalence and correlation of infectious agents in hospitalized children with acute respiratory tract infections in Central China. PLoS One. 2015; 10:e0119170.

13. Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012; 130:25–43.

14. Fritsche PJ, Helbling A, Ballmer-Weber BK. Vaccine hypersensitivity: update and overview. Swiss Med Wkly. 2010; 140:238–246.

15. National Center for Immunization and Respiratory Diseases. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011; 60:1–64.

16. Center for Disease Control and Prevention. Flu vaccination: who should do it, who should not [Internet]. Atlanta, GA: Center for Disease Control and Prevention;2014. cited 2015 Mar 31. Available from: http://www.cdc.gov/flu/pdf/freeresources/general/vaccination-guidelines-factsheet.pdf.

17. Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014; 63:691–697.

18. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2012; 61:613–618.

19. Committee On Infectious Diseases. American Academy Pediatrics. Recommendations for prevention and control of influenza in children, 2014-2015. Pediatrics. 2014; 134:e1503–e1519.

20. The Korean Pediatric Society. Influenza vaccine. In : Lee HJ, editor. Immunization guideline. 7th ed. Seoul: The Korean Pediatric Society;2012. p. 133–146.

21. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12:36–44.

22. Ambrose CS, Wu X, Knuf M, Wutzler P. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine. 2012; 30:886–892.

23. Ambrose CS, Wu X, Caspard H, Belshe RB. Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity. Vaccine. 2014; 32:5546–5548.

24. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007; 356:685–696.

25. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J. 2006; 25:860–869.

26. Moore DL. Canadian Paediatric Society. Infectious Diseases and Immunization Committee. Vaccine recommendations for children and youth for the 2014/2015 influenza season. Paediatr Child Health. 2014; 19:440–444.

27. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine. 2008; 26:Suppl 4. D10–D16.

28. Center for Disease Control and Prevention. ACIP Presentation Slides: February 2015 Meeting [Internet]. Atlanta, GA: Center for Disease Control and Prevention;2015. cited 2015 Jun 22. Available from: http://www.cdc.gov/vaccines/acip/meetings/slides-2015-02.html#flu.

29. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010; 59:1–62.

30. Waibel KH, Gomez R. Ovalbumin content in 2009 to 2010 seasonal and H1N1 monovalent influenza vaccines. J Allergy Clin Immunol. 2010; 125:749–751.

31. McKinney KK, Webb L, Petersen M, Nelson M, Laubach S. Ovalbumin content of 2010-2011 influenza vaccines. J Allergy Clin Immunol. 2011; 127:1629–1632.

32. Roh EJ, Chung EH, Kim JK. Quantitative analysis of egg protein by ELISA in distributed influenza vaccine in Korea. Pediatr Allergy Respir Dis. 2009; 19:345–353.

33. Des Roches A, Paradis L, Gagnon R, et al. Egg-allergic patients can be safely vaccinated against influenza. J Allergy Clin Immunol. 2012; 130:1213–1216.

34. Gagnon R, Primeau MN, Des Roches A, et al. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Immunol. 2010; 126:317–323.

35. Shin WJ, Kim SY, Ahn YM. Follow-up study of children with egg allergy: comorbidity of allergic diseases and factors affecting prognosis. Pediatr Allergy Respir Dis. 2004; 14:87–96.

36. Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M. SNIFFLE Study Investigators. Safety of live attenuated influenza vaccine in atopic children with egg allergy. J Allergy Clin Immunol. 2015; 02. 01. [Epub]. DOI: 10.1016/j.jaci.2014.12.1925.

37. Des Roches A, Samaan K, Graham F, et al. Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine. J Allergy Clin Immunol Pract. 2015; 3:138–139.

38. Turner PJ, Erlewyn-Lajeunesse M. Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children. J Allergy Clin Immunol Pract. 2015; 3:312–313.

39. Greenhawt M, Wang J. Physician compliance with updated practice parameters for influenza vaccination in individuals with egg allergies. J Allergy Clin Immunol Pract. 2013; 1:602–607.

40. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60:1128–1132.

41. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices, United States, 2013-2014. MMWR Recomm Rep. 2013; 62:1–43.

42. Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol. 2014; 134:1016–1025.

43. Kelso JM. Influenza vaccine and egg allergy: nearing the end of an evidence-based journey. J Allergy Clin Immunol Pract. 2015; 3:140–141.

44. Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013; 2:CD000364.

45. Ambrose CS, Dubovsky F, Yi T, Belshe RB, Ashkenazi S. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing. Eur J Clin Microbiol Infect Dis. 2012; 31:2549–2557.

46. Hanania NA, Sockrider M, Castro M, et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004; 113:717–724.

47. Global Initiative for Asthma. Global strategy for asthma management and prevention (2015 update) [Internet]. Global Initiative for Asthma;2015. cited 2015 Apr 11. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2015.pdf.

48. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics. 2009; 124:1549–1555.

49. Wang J, Visness CM, Sampson HA. Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol. 2005; 115:1076–1080.

50. Berns SH, Halm EA, Sampson HA, Sicherer SH, Busse PJ, Wisnivesky JP. Food allergy as a risk factor for asthma morbidity in adults. J Asthma. 2007; 44:377–381.

51. Vogel NM, Katz HT, Lopez R, Lang DM. Food allergy is associated with potentially fatal childhood asthma. J Asthma. 2008; 45:862–866.